{"disease":{"id":"thymoma-and-thymic-carcinoma","name":"thymoma and thymic carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06301945","title":"Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":1020,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT06692062","title":"Hypofractionated Radiotherapy for Thymic Epithelial Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Rongrong Zhou","has_results":false},{"nct_id":"NCT04554524","title":"Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Tang-Du Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}